Clinical Trial Update: Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating GlaxoSmithKline's MenC-TT and Hib-MenC-TT vaccines in infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Hib-MenC-TT vaccine (Haemophilus influenzae type b and meningococcal C tetanus toxoid conjugate vaccine)
• MenC-TT vaccine (Meningococcal C tetanus toxoid conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 2 | Status: COMPLETED